Skip to main content
MCL: Ibrutinib could become the ‘new standard’
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
MCL: Ibrutinib could become the ‘new standard’
User login
Username
Password
Reset your password
Concept
Lead
score
Stem Cell Research and Therapy
1
1
Transplantation
0
0.93
Biologic Therapy
0
0.83
Cell Transplantation
0
0.78
Mantle Cell Lymphoma
0
0.99
Lymphoma
0
0.42
Tyrosine Kinase Inhibitor
0
0.24
Chemotherapy
0
0.17
Spine
0
0.17
Tyrosine Kinase
0
0.17
Neutropenia
0
0.14
Patient Safety
0
0.11
Adverse Effects
0
0.09
Antineoplastic Drug
0
0.09
CAR-T
0
0.09
Europe
0
0.09
Hematology
0
0.09
Hospital
0
0.09
Infestations
0
0.09
Leukopenia
0
0.09
Lymph Node
0
0.09
Monoclonal Antibody
0
0.09
Ohio
0
0.09
Multiple Sclerosis
0
0.07
Toxicology
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Transplantation
0
0.9
Edit Tags